Mounjaro is a registered trademark of Eli Lilly and Company. It is an FDA-approved prescription medicine, and a licensed clinician decides whether it is appropriate for a patient.
People searching for a weight loss price usually want one number. The honest answer starts one step earlier, with what the medicine is approved to treat. That detail changes which pharmacy quote applies to you and which savings terms you can even read.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
Important safety information
Mounjaro carries a boxed warning about the risk of thyroid C-cell tumors. In rodent studies, tirzepatide caused thyroid C-cell tumors. It is not known whether Mounjaro causes these tumors, including medullary thyroid carcinoma, in people.
It must not be used by anyone with a personal or family history of medullary thyroid carcinoma, or by anyone with Multiple Endocrine Neoplasia syndrome type 2. Serious risks described in the FDA labeling include inflammation of the pancreas, low blood sugar when used with insulin or certain other diabetes medicines, serious allergic reactions, kidney injury from dehydration, severe stomach problems, gallbladder problems, worsening of diabetic eye disease, and food entering the lungs during anesthesia or deep sedation. Nausea, diarrhea, reduced appetite, vomiting, constipation, indigestion, and stomach pain are commonly reported.
Read the official Mounjaro Prescribing Information and Medication Guide for the complete boxed warning, approved use, contraindications, warnings, and side effects. A price comparison is not a clinical decision, and only a clinician who has evaluated you can make the second one.
The approved use comes before the price
Mounjaro is approved to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. Its labeling states that it is not for use in people with type 1 diabetes, and Lilly's own product site describes the approved use in the same terms.
Tirzepatide, the active ingredient, is also sold under a separate brand name with its own separate FDA approval for chronic weight management in certain adults. That is a different product with its own label, its own savings terms, and its own price. Two searches that feel identical can point at two different products.
This matters for cost in a very practical way. Pharmacy quotes, manufacturer savings programs, and plan coverage rules are all tied to a specific product and often to the approved use it is prescribed for. Reading terms for one product and budgeting with them for another leads to a surprise at the counter.
So the first question to bring to a clinician is not what something costs. It is what is clinically appropriate for you. The price question becomes answerable only after that.
The four numbers people confuse
A search result can return a manufacturer list price, a pharmacy cash price, an insured cost share, or a savings-card amount. They answer different questions and they are rarely the same.
List price is a reference amount set by the manufacturer before rebates, plan benefits, discounts, and pharmacy charges. Lilly publishes current list-price context in its official Mounjaro pricing FAQ.
Cash price is what one specific pharmacy asks a patient to pay outside insurance. It varies between pharmacies, and it can change between refills.
An insured cost share is what your plan leaves you to pay after it processes the claim, which depends on your formulary, your tier, and where you stand against your deductible.
A savings-card amount applies only after a pharmacy processes the card for a patient who meets the program terms that day.
Compare the same supply
Before collecting quotes, write down the exact strength, the dosage form, the quantity, and the number of days the fill covers. A lower number that covers fewer days is not a better number.
Ask each pharmacy for the final total rather than a range, and ask whether it includes dispensing fees, taxes, delivery, or supplies. Use identical prescription details at every pharmacy you call, or you are not comparing anything.
Ask what happens at the next fill too. A clinician may adjust treatment based on the labeling and on how a patient responds. Price should never drive that decision, but knowing whether the amount changes helps you plan.
Read savings terms in full, not in an ad
Lilly describes current options on its official savings and coverage page. Eligibility can depend on whether you have commercial insurance, whether that plan covers the prescription, and whether the prescription is for the FDA-approved use. People in government programs are often excluded.
A savings card is not insurance. Programs commonly carry a maximum benefit per fill, an annual cap, a limited number of fills, and an end date, and the manufacturer can change the terms. An advertised starting amount is not a quote for every patient.
If the amount at the register does not match what you expected, ask the pharmacist which piece caused it. Eligibility, an annual maximum, the plan response, and the prescription details are all separate causes with separate fixes.
Build the estimate in separate lines
Keep three categories apart on paper. First, the medication charge from the pharmacy for one defined supply. Second, any clinical service fee. Third, laboratory testing, if a clinician orders it.
Separating them tells you where a future increase came from, whether that is a pharmacy price change, a savings program ending, or a change in services. A single blended number hides all of that.
Recheck at every refill. A past receipt is a record of what happened then, not a promise about the next fill.
Where Body Good fits
Body Good provides clinical and administrative services. A licensed clinician reviews your history and decides what is appropriate for you. A program can include follow-up, coverage support, and routing a prescription to a state-licensed pharmacy.
Coverage support means running a benefit check and helping prepare the paperwork a plan asks for. It is help with the process only. Approval and payment are determined by your plan, not by Body Good, and no service can promise a coverage outcome.
Body Good's prices are service fees for the program described during intake. They are not the price of medication, and the cost of medication is separate and not included. They are not a quote for any individual, and eligibility is determined by a clinician.
This website is an information and pricing overview. It takes no payment, collects no protected health information, and hosts no intake form. Intake and checkout take place on joinbodygood.com.
If cost may interrupt treatment
Talk to the prescribing clinician and the pharmacist before skipping a fill or changing how a medicine is used. There may be clinically appropriate options worth discussing.
Be cautious of any seller offering prescription medicine without an evaluation, or one that will not name the dispensing pharmacy. The FDA's BeSafeRx resource explains how to check an online pharmacy before you send money.
Frequently asked questions
Is Mounjaro approved for weight loss?
Mounjaro is approved to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. A different product containing the same active ingredient holds a separate FDA approval for chronic weight management. A clinician can explain which label applies to your situation.
Why do online prices vary so much?
Because they are different kinds of numbers. List price, pharmacy cash price, insured cost share, and savings-card amounts each follow their own rules. Only a pharmacy running your exact prescription can give you a final total.
Can Body Good tell me the medication price?
No. The pharmacy sets and collects the medication charge. Body Good charges separate service fees for clinical and administrative support. Begin the secure intake to provide information for clinical review.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.